Analystreport

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) was given a new $94.00 price target on by analysts at Royal Bank Of Canada. They now have a "buy" rating on the stock.

Eagle Pharmaceuticals, Inc.  (EGRX) 
Last eagle pharmaceuticals, inc. earnings: 3/2 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: investor.eagleus.com